Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD

NCT00191035 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

520

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: Atomoxetine

Sponsor

Eli Lilly and Company